about
Genotyping HIV-1 and HCV strains by a combinatorial DNA melting assay (COMA)Cellular HIV-1 DNA levels in drug sensitive strains are equivalent to those in drug resistant strains in newly-diagnosed patients in EuropePatterns of transmitted HIV drug resistance in Europe vary by risk groupTrends and predictors of transmitted drug resistance (TDR) and clusters with TDR in a local Belgian HIV-1 epidemicEvidence of two distinct subsubtypes within the HIV-1 subtype A radiation.The global spread of HIV-1 subtype B epidemic.Effects of CCR5-Delta32, CCR2-64I, and SDF-1 3'A alleles on HIV-1 disease progression: An international meta-analysis of individual-patient data.Molecular beacon-based real-time PCR detection of primary isolates of Salmonella Typhimurium and Salmonella Enteritidis in environmental and clinical samples.Use of coreceptors other than CCR5 by non-syncytium-inducing adult and pediatric isolates of human immunodeficiency virus type 1 is rare in vitroRe-analysis of human immunodeficiency virus type 1 isolates from Cyprus and Greece, initially designated 'subtype I', reveals a unique complex A/G/H/K/? mosaic pattern.Quantitation of human immunodeficiency virus type 1 DNA forms with the second template switch in peripheral blood cells predicts disease progression independently of plasma RNA loadIncrease in transmitted resistance to non-nucleoside reverse transcriptase inhibitors among newly diagnosed HIV-1 infections in Europe.Architectural insight into inovirus-associated vectors (IAVs) and development of IAV-based vaccines inducing humoral and cellular responses: implications in HIV-1 vaccinesGenetic analysis of human immunodeficiency virus type 1 strains from patients in Cyprus: identification of a new subtype designated subtype I.CCR5 promoter polymorphisms in a Kenyan perinatal human immunodeficiency virus type 1 cohort: association with increased 2-year maternal mortality.Viral correlates of HIV-1 disease.Treatment-associated polymorphisms in protease are significantly associated with higher viral load and lower CD4 count in newly diagnosed drug-naive HIV-1 infected patientsDramatic rise in plasma viremia after CD8(+) T cell depletion in simian immunodeficiency virus-infected macaques.Effects of in vivo CD8(+) T cell depletion on virus replication in rhesus macaques immunized with a live, attenuated simian immunodeficiency virus vaccine.Global genetic variation of HIV-1 infection.Limited cross-border infections in patients newly diagnosed with HIV in EuropeHIV-1 integrase: from biology to chemotherapeutics.Short communication: molecular epidemiology of HIV type 1 infection in northern Greece (2009-2010): evidence of a transmission cluster of HIV type 1 subtype A1 drug-resistant strains among men who have sex with men.HIV-1 vaccine strategies utilizing viral vectors including antigen- displayed inoviral vectors.Global Dispersal Pattern of HIV Type 1 Subtype CRF01_AE: A Genetic Trace of Human Mobility Related to Heterosexual Sexual Activities Centralized in Southeast Asia.Cellular HIV type 1 DNA levels are equivalent among drug-sensitive and drug-resistant strains in newly diagnosed and antiretroviral naive patients.Re-analysis of unassigned hepatitis C virus (HCV) strain CYHCV025: Evidence of a highly divergent lineage within genotype 1.Targeting Pattern Recognition Receptors (PRR) for Vaccine Adjuvantation: From Synthetic PRR Agonists to the Potential of Defective Interfering Particles of Viruses.Near-full genome characterisation of two natural intergenotypic 2k/1b recombinant hepatitis C virus isolates.Restrictions for reimbursement of interferon-free direct-acting antiviral drugs for HCV infection in Europe.Molecular epidemiology of hepatitis C infection in Cyprus: evidence of polyphyletic infection.Near-full genome characterization of unclassified hepatitis C virus strains relating to genotypes 1 and 4.Molecular characterization of HIV type 1 strains from newly diagnosed patients in Cyprus (2007-2009) recovers multiple clades including unique recombinant strains and lack of transmitted drug resistance.Development of a molecular-beacon-based multi-allelic real-time RT-PCR assay for the detection of human coronavirus causing severe acute respiratory syndrome (SARS-CoV): a general methodology for detecting rapidly mutating viruses.Cellular HIV-1 DNA load predicts HIV-RNA rebound and the outcome of highly active antiretroviral therapy.Transmission of drug-resistant HIV-1 is stabilizing in Europe.Near full-length genetic analysis of HIV sequences derived from Cyprus: evidence of a highly polyphyletic and evolving infection.Genetic analysis of HIV type 1 strains from newly infected untreated patients in cyprus: high genetic diversity and low prevalence of drug resistance.Emergence of minor populations of human immunodeficiency virus type 1 carrying the M184V and L90M mutations in subjects undergoing structured treatment interruptions.T cell receptor excision circles and HIV-1 2-LTR episomal DNA to predict AIDS in patients not receiving effective therapy.
P50
Q27485356-457008BD-D28C-47A6-8814-972DCD9669F9Q28474278-5F6289EA-39BE-4707-AD30-C83CBED6F564Q28537726-5BCF3236-8B87-4E55-900C-736F3878A7C3Q28540490-DFA8802D-63BA-4509-AF51-7B90D5458F72Q30328346-10B6243A-893E-4CAA-BC69-7805CCBCBC20Q30388926-F76CDB11-36EE-400E-972F-2F941F001B96Q30664904-C7F595D3-89DA-4A41-88B2-911B115AD908Q33447889-819F5F9E-C5D3-4A33-849E-E37A19FE3D69Q33785490-AD5A6357-9A9E-4C01-897E-ABD8436C39D6Q33932939-3810D4B2-D3B2-444F-8D53-18BAFA9DF2A9Q34348055-634E66BD-B22D-4499-893E-4B8FDA9604BEQ34469240-5645A966-C201-4892-A97A-75FE64FCB296Q34774808-D915E8FA-B5EE-41FD-B62E-A4EFDA5E47FDQ35847747-5DDBA3BF-CA34-4642-9B57-6E5CC584B578Q36004314-E06D9906-5A37-4C87-B1B4-7F81AD1E367FQ36107560-28790835-38B6-419B-9B0B-827530D12492Q36367759-D4D49E0E-9E23-44CD-9096-AA47A5920FAAQ36368095-A59EEA95-7C50-4149-8AE0-6470F881525EQ36404673-C9EBFD0F-86FF-42FE-B06A-3F4A63431128Q36536204-31C5FE8D-E2A4-46BB-91D8-D630DB084DD2Q36766901-7ACC441A-E0E2-40E0-82BD-C7E01BC6C261Q36879253-9C092E92-E95B-43CB-BD59-B06BB354A846Q37610697-A5A3926B-2C01-4EE0-B94C-97F6164254D0Q38187155-9A9737B0-41CE-4B88-A469-A2FA31A3355AQ38875822-B20AE75D-B610-416C-B0E2-F0F273DBD560Q38876955-17A419E5-1B69-4099-AB71-34BD77B989B8Q38971336-74A928C3-56BD-4910-A045-5DCE2946020DQ39432584-7094965F-B5C3-433C-B0E4-330231CA3CC5Q40788533-8DAFD719-EBFE-48AF-9451-87DA98C0CEF5Q41922681-6A68802F-398C-4812-8835-30A23E75090DQ42984113-C89A6663-A56B-481E-87FC-B3EA1234E69DQ43041573-A623D42B-ED8B-4991-9F15-4EF020C5C7F9Q43629185-5DF9A72E-BCE5-4F7B-B55F-2D579668CB0CQ44233095-2B81F9F7-ACD4-4688-BEC9-788F5D532274Q44488396-5019F368-CEDD-420A-9E04-72095CEDC68CQ44591236-FEA8FB29-3D90-4E5C-A460-C35D8777045CQ44979219-175CBBF2-5F99-46DB-ABB3-5F5D29ED7672Q45344600-43270676-3EE4-4958-BF38-483F7F5E1FE9Q45709309-47900A14-A6B9-4BC5-A204-900A64DF8C4CQ45881305-1E193FA5-7AA7-48F9-9F15-238DF3ADCC98
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Leondios G Kostrikis
@ast
Leondios G Kostrikis
@en
Leondios G Kostrikis
@es
Leondios G Kostrikis
@nl
type
label
Leondios G Kostrikis
@ast
Leondios G Kostrikis
@en
Leondios G Kostrikis
@es
Leondios G Kostrikis
@nl
prefLabel
Leondios G Kostrikis
@ast
Leondios G Kostrikis
@en
Leondios G Kostrikis
@es
Leondios G Kostrikis
@nl
P106
P1153
6701410435
P31
P496
0000-0002-5340-7109